- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07454330
Study of a Support Program for Quality of Life in Chinese Cancer Patients and Survivors
April 29, 2026 updated by: Memorial Sloan Kettering Cancer Center
A Multicomponent Support Program to Enhance Quality of Life in Chinese Cancer Patients and Survivors (MSP-CCS): Pilot Optimization Trial and Implementation Outcomes
The purpose of this study is to evaluate different combinations of cancer education sessions, counseling sessions, and peer support meetings developed for Chinese cancer patients and survivors.
The researchers will look at whether the combinations are practical and effective, and how they impact participants' quality of life.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
64
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Jennifer Leng, MD, MPH
- Phone Number: 646-888-8057
Study Contact Backup
- Name: Florence Lui, PhD
- Phone Number: 646-888-8375
- Email: luif@mskcc.org
Study Locations
-
-
New Jersey
-
Basking Ridge, New Jersey, United States, 07920
- Recruiting
- Memorial Sloan Kettering Basking Ridge (All Protocol Activities)
-
Contact:
- Florence Lui, PhD
- Phone Number: 646-888-8375
-
Middletown, New Jersey, United States, 07748
- Recruiting
- Memorial Sloan Kettering Monmouth (All Protocol Activities)
-
Contact:
- Florence Lui, PhD
- Phone Number: 646-888-8375
-
Montvale, New Jersey, United States, 07645
- Recruiting
- Memorial Sloan Kettering Bergen (All Protocol Activities)
-
Contact:
- Florence Lui, PhD
- Phone Number: 646-888-8375
-
-
New York
-
Commack, New York, United States, 11725
- Recruiting
- Memorial Sloan Kettering Cancer Center Suffolk- Commack (All Protocol Activities)
-
Contact:
- Florence Lui, PhD
- Phone Number: 646-888-8375
-
Harrison, New York, United States, 10604
- Recruiting
- Memorial Sloan Kettering Westchester (All Protocol Activities)
-
Contact:
- Florence Lui, PhD
- Phone Number: 646-888-8375
-
New York, New York, United States, 10065
- Recruiting
- Memorial Sloan Kettering Cancer Center (All Protocol Activities)
-
Contact:
- Jennifer Leng, MD, MPH
- Phone Number: 646-888-8057
-
Principal Investigator:
- Florence Lui, PhD
-
Contact:
- Florence Lui, PhD
- Phone Number: 646-888-8375
-
Uniondale, New York, United States, 11553
- Recruiting
- Memorial Sloan Kettering Nassau (All protocol activities)
-
Contact:
- Florence Lui, PhD
- Phone Number: 646-888-8375
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Diagnosed with cancer (any type/stage) (per EMR for MSK patients or self-report for external participants) within the last 5 years
- Age ≥ 18 years (per EMR for MSK patients or self-report for external participants)
Self-Report Criteria:
- Of Chinese descent
- Speaks Mandarin "well" or "very well"
- Moderately low HRQOL (<70 FACT-G score)4, 48
- Resides in New York or New Jersey
- Agrees to participate via telehealth (video or phone)
- Agrees to be audio-recorded
Exclusion Criteria:
Self-Report Criteria:
- Per PI determination, requires a higher level of care for current passive or active suicidal ideation than current protocol is able to provide. If a participant receives a score of > 0 on item 9 of the PHQ-9,5 they will be referred to study PI for further evaluation using the Columbia-Suicide Severity Rating Scale. They will be excluded from participation in this study if there is presence of suicidal risk, determined by affirmative response(s) on the Columbia-Suicide Severity Rating Scale (C-SSRS)
- Too ill to participate determined by the question: "Do you feel too ill to participate because of communication problems, uncontrollable pain, or other symptoms that prevent you from participating?"
- Cognitive impairment (Montreal Cognitive Assessment 5 Minute - telephone version with a score < 12)
- Per consenting professional determination, unable to understand the informed consent procedure
- Participation in study #14-076: Adaptation of Individual Meaning-Centered Psychotherapy for Chinese immigrant cancer patients)
- Currently receiving/have received psychotherapy/counseling/peer support within the last 6 months (patients being treated solely with psychotropic medications will not be excluded if they are not receiving psychotherapy/counseling/peer support)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Factorial Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: 1 - Cancer Education + Meaning-Centered Counseling + Peer Support + Enhanced Standard Care
All participants will also receive cancer information materials and resources.
Cancer education sessions, will have 3 weekly sessions.Counseling sessions, will have 3 weekly sessions.
Peer support meetings, will have 3 monthly meetings.
|
Cancer Education on side effects and their management, treatment options, advance care planning, and survivorship.
Each session will last about 30-60 minutes and will be completed over the phone or by video call.
Meaning-centered counseling aims to activate culturally relevant meaning-focused coping strategies in Chinese-speaking patients and survivors (CCS).
Each session will last about 45-60 minutes and will be completed over the phone or by video call.
Peer support aims to increase social support for CCS to decrease cancer stigma, which has been associated with greater psychological distress, especially among less acculturated Chinese immigrant CCS.
The meetings will include up to 6-8 Mandarin-speaking patients and survivors and will last about 90 minutes.
enhanced standard care ( written cancer information materials in Chinese and referral to counseling)
|
|
Experimental: 2 - Cancer Education + Meaning-Centered Counseling + Enhanced Standard Care
All participants will also receive cancer information materials and resources.
Cancer education sessions, will have 3 weekly sessions.Counseling sessions, will have 3 weekly sessions.
|
Cancer Education on side effects and their management, treatment options, advance care planning, and survivorship.
Each session will last about 30-60 minutes and will be completed over the phone or by video call.
Meaning-centered counseling aims to activate culturally relevant meaning-focused coping strategies in Chinese-speaking patients and survivors (CCS).
Each session will last about 45-60 minutes and will be completed over the phone or by video call.
enhanced standard care ( written cancer information materials in Chinese and referral to counseling)
|
|
Experimental: 3 - Cancer Education + Peer Support + Enhanced Standard Care
All participants will also receive cancer information materials and resources.
Cancer education sessions, will have 3 weekly sessions.
Peer support meetings, will have 3 monthly meetings.
|
Cancer Education on side effects and their management, treatment options, advance care planning, and survivorship.
Each session will last about 30-60 minutes and will be completed over the phone or by video call.
Peer support aims to increase social support for CCS to decrease cancer stigma, which has been associated with greater psychological distress, especially among less acculturated Chinese immigrant CCS.
The meetings will include up to 6-8 Mandarin-speaking patients and survivors and will last about 90 minutes.
enhanced standard care ( written cancer information materials in Chinese and referral to counseling)
|
|
Experimental: 4 - Cancer Education + Enhanced Standard Care
All participants will also receive cancer information materials and resources.
Cancer education sessions, will have 3 weekly sessions.
|
Cancer Education on side effects and their management, treatment options, advance care planning, and survivorship.
Each session will last about 30-60 minutes and will be completed over the phone or by video call.
enhanced standard care ( written cancer information materials in Chinese and referral to counseling)
|
|
Experimental: 5 - Meaning-Centered Counseling + Peer Support + Enhanced Standard Care
All participants will also receive cancer information materials and resources.Counseling sessions, will have 3 weekly sessions.
Peer support meetings, will have 3 monthly meetings
|
Meaning-centered counseling aims to activate culturally relevant meaning-focused coping strategies in Chinese-speaking patients and survivors (CCS).
Each session will last about 45-60 minutes and will be completed over the phone or by video call.
Peer support aims to increase social support for CCS to decrease cancer stigma, which has been associated with greater psychological distress, especially among less acculturated Chinese immigrant CCS.
The meetings will include up to 6-8 Mandarin-speaking patients and survivors and will last about 90 minutes.
enhanced standard care ( written cancer information materials in Chinese and referral to counseling)
|
|
Experimental: 6 - Meaning-Centered Counseling- + Enhanced Standard Care
All participants will also receive cancer information materials and resources.
Counseling sessions, will have 3 weekly sessions.
|
Meaning-centered counseling aims to activate culturally relevant meaning-focused coping strategies in Chinese-speaking patients and survivors (CCS).
Each session will last about 45-60 minutes and will be completed over the phone or by video call.
enhanced standard care ( written cancer information materials in Chinese and referral to counseling)
|
|
Experimental: 7 - Peer Support + Enhanced Standard Care
All participants will also receive cancer information materials and resources.
Peer support meetings, will have 3 monthly meetings
|
Peer support aims to increase social support for CCS to decrease cancer stigma, which has been associated with greater psychological distress, especially among less acculturated Chinese immigrant CCS.
The meetings will include up to 6-8 Mandarin-speaking patients and survivors and will last about 90 minutes.
enhanced standard care ( written cancer information materials in Chinese and referral to counseling)
|
|
Active Comparator: 8 - Enhanced Standard Care
All participants will also receive cancer information materials and resources.
|
enhanced standard care ( written cancer information materials in Chinese and referral to counseling)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Proportion of eligible participants who enroll in the trial.
Time Frame: 2 years
|
2 years
|
|
|
Proportion of participants who complete treatment
Time Frame: 24 weeks
|
Pproportion of assessments that are completed, with completion defined as submitting the 24-week assessment with a minimum of the FACT-G completed.
|
24 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Florence Lui, PhD, Memorial Sloan Kettering Cancer Center
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 27, 2026
Primary Completion (Estimated)
February 1, 2028
Study Completion (Estimated)
February 1, 2028
Study Registration Dates
First Submitted
March 2, 2026
First Submitted That Met QC Criteria
March 2, 2026
First Posted (Actual)
March 6, 2026
Study Record Updates
Last Update Posted (Actual)
May 1, 2026
Last Update Submitted That Met QC Criteria
April 29, 2026
Last Verified
April 1, 2026
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 26-025
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
Memorial Sloan Kettering Cancer Center supports the international committee of medical journal editors (ICMJE) and the ethical obligation of responsible sharing of data from clinical trials.
The protocol summary, a statistical summary, and informed consent form will be made available on clinicaltrials.gov
when required as a condition of Federal awards, other agreements supporting the research and/or as otherwise required.
Requests for deidentified individual participant data can be made beginning 12 months after publication and for up to 36 months post publication.
Deidentified individual participant data reported in the manuscript will be shared under the terms of a Data Use Agreement and may only be used for approved proposals.
Requests may be made to: crdatashare@mskcc.org.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cancer
-
Cellworks Group Inc.RecruitingCancer | Relapsed Cancer | Refractory CancerUnited States
-
University of Michigan Rogel Cancer CenterCompletedCancer Liver | Cancer Brain | Cancer Head &Neck | Cancer PelvisUnited States
-
Yale UniversityNational Institute of Nursing Research (NINR); The Glimpse Group IncRecruitingCancer | Adolescent Cancer | Young Adult CancerUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI); Atrium Health Wake Forest BaptistRecruitingCancer | Adolescent Cancer | Young Adult CancerUnited States
-
Vanderbilt-Ingram Cancer CenterEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedAdvanced Cancer | Relapsed Cancer | Refractory CancerUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedStage III Pancreatic Cancer | Stage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage IV Gastric Cancer | Stage IVA Colorectal Cancer | Stage IVA Pancreatic Cancer | Stage IVB Colorectal Cancer | Stage IVB Pancreatic Cancer | Stage IIIA Gastric Cancer | Stage IIIB Gastric Cancer | Stage IIIC Gastric... and other conditionsUnited States
-
Second Affiliated Hospital of Soochow UniversityNot yet recruitingCancer | Solid Cancer
-
New Mexico Cancer Research AllianceOhio State University Comprehensive Cancer Center; H. Lee Moffitt Cancer Center...RecruitingCancer | Cancer RiskUnited States
-
Children's Hospital of PhiladelphiaCompletedCancer | Childhood CancerUnited States
-
University of California, San FranciscoBristol-Myers Squibb; PfizerTerminatedStage IIIA Rectal Cancer | Stage IIIB Rectal Cancer | Stage IIIC Rectal Cancer | Metastatic Colorectal Adenocarcinoma | Metastatic Colon Adenocarcinoma | Metastatic Rectal Adenocarcinoma | Stage IIIA Colon Cancer | Stage IIIB Colon Cancer | Stage IIIC Colon Cancer | Stage IV Colon Cancer | Stage IV Rectal... and other conditionsUnited States
Clinical Trials on Cancer Education
-
Duke UniversityCancer and Leukemia Group B; Durham VA Medical CenterCompletedSmoking Cessation | Tobacco Use Disorder | Lung CancerUnited States
-
Toros UniversityNot yet recruitingCervical Cancer Screening | Breast Cancer Screening | Colorectal Cancer Screening | Cancer Prevention Behavior
-
Ankara UniversityNot yet recruitingCancer | Education | Caregiver | Randomised Controlled TrialTurkey
-
National Cheng Kung UniversityCompleted
-
Thaddeus PaceCompletedCancer Survivors | Informal Cancer Caregivers (Family and Friends of Cancer Survivors)United States
-
Georgetown UniversityU.S. Army Medical Research and Development CommandCompleted
-
University of California, DavisCalifornia Academy of Family PhysiciansCompletedColorectal NeoplasmsUnited States
-
University of North Carolina, Chapel HillNational Cancer Institute (NCI); Duke UniversityCompletedEarly-Stage Breast CancerUnited States
-
Istanbul Aydın UniversityActive, not recruiting